Literature DB >> 28648226

Australasian Sleep Association position statement regarding the use of psychological/behavioral treatments in the management of insomnia in adults.

Melissa Ree1, Moira Junge2, David Cunnington3.   

Abstract

Insomnia disorder is a high prevalence condition with a high disease burden, which, left untreated, can increase risk of poorer health outcomes. Due to Insomnia's tendency towards having a chronic course, long-term treatment approaches are required to reduce the impact of Insomnia over time. After reviewing the available literature, The Australasian Sleep Association (ASA) recommends Cognitive Behavior Therapy for Insomnia (CBT-I) as a first line treatment in the management of Insomnia. The ASA notes that in addition to CBT-I, there is emerging evidence for the use of Mindfulness Based Therapy for Insomnia when used in combination with behavioural techniques (MBT-I). CBT-I should be used whenever possible, and medications should be limited to the lowest necessary dose and shortest necessary duration. CBT-I, whilst the most effective long-term treatment, does not work for everybody across all circumstances, so there will be circumstances in which other treatments are required (e.g., pharmacotherapy). Improving access to CBT-I is an important issue which will involve raising awareness of the effectiveness of CBT-I, increasing the number of trained practitioners, and the development of effective low intensity treatments that can be offered in the first instance.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cognitive Behaviour Therapy-Insomnia; Insomnia; Treatment effectiveness; Treatment guidelines

Mesh:

Year:  2017        PMID: 28648226     DOI: 10.1016/j.sleep.2017.03.017

Source DB:  PubMed          Journal:  Sleep Med        ISSN: 1389-9457            Impact factor:   3.492


  18 in total

1.  Behavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment.

Authors:  Jack D Edinger; J Todd Arnedt; Suzanne M Bertisch; Colleen E Carney; John J Harrington; Kenneth L Lichstein; Michael J Sateia; Wendy M Troxel; Eric S Zhou; Uzma Kazmi; Jonathan L Heald; Jennifer L Martin
Journal:  J Clin Sleep Med       Date:  2021-02-01       Impact factor: 4.062

2.  Poorer sleep quality predicts melatonin response in patients with traumatic brain injury: findings from a randomized controlled trial.

Authors:  Natalie A Grima; Shantha M W Rajaratnam; Darren Mansfield; Dean McKenzie; Jennie L Ponsford
Journal:  J Clin Sleep Med       Date:  2021-08-01       Impact factor: 4.324

3.  Psychological Sleep Interventions for Migraine and Tension-Type Headache: A Systematic Review and Meta-Analysis.

Authors:  Daniel P Sullivan; Paul R Martin; Mark J Boschen
Journal:  Sci Rep       Date:  2019-04-23       Impact factor: 4.379

4.  Zao Ren An Shen capsule for chronic insomnia: Study protocol for a randomized, placebo-controlled trial.

Authors:  Yoann Birling; Alan Bensoussan; Jerome Sarris; Nicole Avard; Xiaoshu Zhu
Journal:  Medicine (Baltimore)       Date:  2019-04       Impact factor: 1.817

5.  Traditional Chinese medicine non-pharmaceutical therapies for chronic adult insomnia: A Bayesian network meta-analysis protocol.

Authors:  Feizhou Li; Bo Xu; Ping Wang; Ling Liu
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

Review 6.  Sleep Abnormalities in Schizophrenia: State of the Art and Next Steps.

Authors:  Fabio Ferrarelli
Journal:  Am J Psychiatry       Date:  2021-03-17       Impact factor: 18.112

7.  Effect of depression, anxiety, and stress symptoms on response to cognitive behavioral therapy for insomnia in patients with comorbid insomnia and sleep apnea: a randomized controlled trial.

Authors:  Alexander Sweetman; Leon Lack; R Doug McEvoy; Peter G Catcheside; Nick A Antic; Ching Li Chai-Coetzer; James Douglas; Amanda O'Grady; Nicola Dunn; Jan Robinson; Denzil Paul; Simon Smith
Journal:  J Clin Sleep Med       Date:  2021-03-01       Impact factor: 4.062

Review 8.  Efficacy and Safety of Banxia Formulae for Insomnia: A Systematic Review and Meta-Analysis of High-Quality Randomized Controlled Trials.

Authors:  Yan-Hua Lin; Cong Chen; Xiu Zhao; Yi-Fei Mao; Guang-Xin Xiang; Meng-Qi Yang; Yong-Mei Song
Journal:  Evid Based Complement Alternat Med       Date:  2021-05-26       Impact factor: 2.629

9.  Primary care management of chronic insomnia: a qualitative analysis of the attitudes and experiences of Australian general practitioners.

Authors:  Jenny Haycock; Nicole Grivell; Elizabeth Hoon; Anne Redman; Bandana Saini; Andrew Vakulin; Leon Lack; Nicole Lovato; Alexander Sweetman; Nicholas Zwar; Nigel Stocks; Oliver Frank; Sutapa Mukherjee; Robert Adams; R Doug McEvoy
Journal:  BMC Fam Pract       Date:  2021-07-22       Impact factor: 2.497

10.  Effects of acupuncture on the hypothalamus-pituitary-adrenal axis in chronic insomnia patients: a study protocol for a randomized controlled trial.

Authors:  Chengyong Liu; Shiyu Zheng; Wenzhong Wu; Xiaoqiu Wang; Shan Qin; Yanan Zhao; Hanqing Xi; Qingyun Wan
Journal:  Trials       Date:  2019-12-30       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.